Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2017.0058
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with a 5-year survival of 8%. Current therapeutic regimens are largely ineffective and underscore the need for novel treatment strategies. Chromosomal rearrangements involving the… read more here.
Keywords: ductal adenocarcinoma; alk; exon alk; pancreatic ductal ... See more keywords